Introduction
Before the identification of McLeod neuroacanthocytosis syndrome (MLS) and choreaacanthocytosis (ChAc) as genetically distinct disorders, these two disorders, which have remarkable clinical similarities, were confusinglylumped together under the term ''neuroacanthocytosis.'' Genetic diagnosis has enabled us to identify features that initially appeared to be specific to each of the disorders. However, with increased availability of genetic and proteinbased testing, it has become apparent that certain phenotypic features thought to be specific to one disorder may indeed be found in the other, such as feeding dystonia 1 and head drops. 2 Here we provide video documentation of a case of MLS that evolved from chorea to parkinsonism, a disease course that has not previously been reported on, and that is more typical of ChAc. Neuroradiological studies demonstrate progressive striatal atrophy.
Case report
The patient was a chemical engineer, the elder of two brothers affected with MLS, as previously described. 6 He presented at age 56 and reported a 9-year history of a chorea associated with episodic major depression. He noted reduced ability to concentrate at work and diminished ability to control his emotions in everyday life. In addition, he 
